GlassScriptPhysician profile
Grant P Redrow
NPI 1316293152
$5,968.95
in general payments reported to CMS, 2019-2025
35 companies · $374 in 2025
The $374 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $65.35 · 2022: $303 · 2023: $1,444 · 2024: $3,311 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,846 · Travel and Lodging: $1,761 · Education: $1,500 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,845.55 |
| Travel and Lodging | $1,760.72 |
| Education | $1,500.00 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,012.47 | 2023-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $470.34 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Ams 700 |
| Astellas Pharma US INC | $153.71 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $150.49 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Abbvie INC. | $148.66 | 2019-2025 | |
| Urogen Pharma, INC. | $79.62 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $63.12 | 2019-2022 | |
| Angiodynamics, INC. | $58.52 | 2023 | Nanoknife |
| Antares Pharma, INC. | $56.90 | 2019-2024 | Tlando, Xyosted |
| Endo Pharmaceuticals INC. | $56.28 | 2019 | |
| Teleflex LLC | $52.52 | 2025 | Urolift, Barrigel |
| Progenics Pharmaceuticals, INC. | $48.47 | 2022 | |
| Medtronic, INC. | $45.28 | 2024-2025 | Interstim |
| 180 Medical, INC. | $43.82 | 2022-2024 | Gentlecath |
| Abc Home Medical Supply, INC. | $42.40 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $42.02 | 2019-2022 | |
| Convatec INC. | $39.43 | 2025 | |
| Accord Healthcare, INC. | $38.41 | 2022 | |
| Coloplast Corp | $34.64 | 2024 | |
| Amgen INC. | $27.44 | 2019 | |
| Inspire Medical Systems, INC. | $25.55 | 2025 | Inspire |
| Verity Pharmaceuticals INC. | $25.16 | 2025 | Trelstar |
| Merck Sharp & Dohme LLC | $24.78 | 2022 | |
| Endo USA, INC. | $24.14 | 2025 | Xiaflex, Aveed |
| Healthtronics Stone Solutions, LLC | $23.33 | 2019 | |
| Axonics, INC. | $23.04 | 2024 | Axonics |
| Olympus America INC. | $21.41 | 2023 | Itind System |
| Novartis Pharmaceuticals Corporation | $21.08 | 2025 | |
| Genzyme Corporation | $20.62 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.00 | 2019 | |
| Cook Medical LLC | $18.98 | 2024 | Resonance |
| Photocure INC | $18.65 | 2019 | |
| Mission Pharmacal Company | $13.23 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.07 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Redrow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.